| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |